Bill Commons

CA AB 2249

enacted

Cannabis: labels, packaging, and advertising.

California · 2025-2026 Regular Session · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did CA AB 2249 pass?

Yes. CA AB 2249 has been enacted into law. Latest recorded action (2026-08-31): Chaptered by Secretary of State - Chapter 164, Statutes of 2026.

What is CA AB 2249 about?

The Control, Regulate and Tax Adult Use of Marijuana Act (AUMA) , an initiative measure approved as Proposition 64 at the November 8, 2016, statewide general election, authorizes a person who obtains a state license under AUMA to engage in commercial adult-use cannabis activity pursuant to that license and applicable local ordinances. AUMA authorizes the Legislature to amend by majority vote certain provisions of the act to implement specified substantive provisions, provided that the amendments are consistent with and further the purposes and intent of AUMA. The Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) , among other things, consolidates the licensure and regulation of commercial medicinal and adult-use cannabis activities under the jurisdiction of the Department of Cannabis Control, including retail commercial cannabis activity. MAUCRSA prohibits a person engaged in commercial cannabis activity, whether licensed or unlicensed, from engaging in specified advertising or marketing activities, including publishing or disseminating advertising or marketing that is attractive to children. MAUCRSA also places specified requirements on the packaging and labeling of cannabis and cannabis products, including prohibiting packages and labels from being made to be attractive to children. This bill, commencing January 1, 2028, would define "attractive to children" to mean designed or likely to appeal to individuals under 21 years of age, as specified. The bill would authorize the department to adopt regulations to address additional packaging and labeling design elements or product characteristics that pose heightened risk to children. The bill would require the department to develop compliance assessment resources to assist licensees in self-evaluating whether packaging or labeling is attractive to children.

Who sponsors CA AB 2249?

Irwin is the primary sponsor of CA AB 2249.

Description

The Control, Regulate and Tax Adult Use of Marijuana Act (AUMA) , an initiative measure approved as Proposition 64 at the November 8, 2016, statewide general election, authorizes a person who obtains a state license under AUMA to engage in commercial adult-use cannabis activity pursuant to that license and applicable local ordinances. AUMA authorizes the Legislature to amend by majority vote certain provisions of the act to implement specified substantive provisions, provided that the amendments are consistent with and further the purposes and intent of AUMA. The Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) , among other things, consolidates the licensure and regulation of commercial medicinal and adult-use cannabis activities under the jurisdiction of the Department of Cannabis Control, including retail commercial cannabis activity. MAUCRSA prohibits a person engaged in commercial cannabis activity, whether licensed or unlicensed, from engaging in specified advertising or marketing activities, including publishing or disseminating advertising or marketing that is attractive to children. MAUCRSA also places specified requirements on the packaging and labeling of cannabis and cannabis products, including prohibiting packages and labels from being made to be attractive to children. This bill, commencing January 1, 2028, would define "attractive to children" to mean designed or likely to appeal to individuals under 21 years of age, as specified. The bill would authorize the department to adopt regulations to address additional packaging and labeling design elements or product characteristics that pose heightened risk to children. The bill would require the department to develop compliance assessment resources to assist licensees in self-evaluating whether packaging or labeling is attractive to children.

Introduced
2026-03-16
Latest action
2026-08-31 — Chaptered by Secretary of State - Chapter 164, Statutes of 2026.
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Irwinauthor

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-08-31

    Chaptered by Secretary of State - Chapter 164, Statutes of 2026.

    became-law

  2. 2026-08-31

    Approved by the Governor.

    executive-signature

  3. 2026-08-27

    Enrolled and presented to the Governor at 4 p.m.

    executive-receipt

  4. 2026-08-20

    Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 69. Noes 1.).

    amendment-passage,committee-passage,committee-passage-favorable

  5. 2026-08-20

    Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 69. Noes 1. Page 6326.).

    amendment-passage,committee-passage,committee-passage-favorable

  6. 2026-08-19

    In Assembly. Concurrence in Senate amendments pending.

  7. 2026-08-19

    Read third time. Passed. Ordered to the Assembly. (Ayes 37. Noes 0.).

    passage,reading-1,reading-3

  8. 2026-08-19

    Read third time. Passed. Ordered to the Assembly. (Ayes 38. Noes 0. Page 5561.).

  9. 2026-08-17

    Read second time. Ordered to third reading.

    reading-1,reading-2,reading-3

  10. 2026-08-13

    Read second time and amended. Ordered returned to second reading.

    amendment-passage,reading-1,reading-2

  11. 2026-08-13

    From committee: Amend, and do pass as amended. (Ayes 7. Noes 0.) (August 13).

    amendment-introduction,amendment-passage,committee-passage

  12. 2026-06-22

    In committee: Referred to APPR. suspense file.

    referral-committee

  13. 2026-06-08

    From committee: Do pass and re-refer to Com. on APPR. (Ayes 9. Noes 0.) (June 8). Re-referred to Com. on APPR.

    committee-passage,committee-passage-favorable,referral-committee

  14. 2026-06-03

    Referred to Com. on B. P. & E.D.

    referral-committee

  15. 2026-05-27

    In Senate. Read first time. To Com. on RLS. for assignment.

    reading-1,referral-committee

  16. 2026-05-26

    Read third time. Passed. Ordered to the Senate. (Ayes 69. Noes 0.)

    passage,reading-1,reading-3

  17. 2026-05-26

    Read third time. Passed. Ordered to the Senate. (Ayes 69. Noes 0. Page 5311.)

  18. 2026-05-22

    Read third time and amended. Ordered to third reading. (Page 5273.)

    amendment-passage,reading-1,reading-3

  19. 2026-05-18

    Read second time. Ordered to third reading.

    reading-1,reading-2,reading-3

  20. 2026-05-14

    From committee: Do pass. (Ayes 14. Noes 0.) (May 14).

    committee-passage,committee-passage-favorable

  21. 2026-05-06

    In committee: Set, first hearing. Referred to APPR. suspense file.

    referral-committee

  22. 2026-04-16

    Re-referred to Com. on APPR.

    referral-committee

  23. 2026-04-15

    Read second time and amended.

    amendment-passage,reading-1,reading-2

  24. 2026-04-14

    From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 17. Noes 0.) (April 14).

    amendment-introduction,amendment-passage,committee-passage,referral-committee

  25. 2026-03-17

    Re-referred to Com. on B. & P.

    referral-committee

  26. 2026-03-16

    Referred to Com. on B. & P.

    referral-committee

  27. 2026-03-16

    From committee chair, with author's amendments: Amend, and re-refer to Com. on B. & P. Read second time and amended.

    amendment-introduction,amendment-passage,committee-passage,reading-1,reading-2,referral-committee

  28. 2026-02-20

    From printer. May be heard in committee March 22.

  29. 2026-02-19

    Read first time. To print.

    reading-1

Versions

  • 02/19/26 - Introduced — 2026-02-19Compare
  • 03/16/26 - Amended Assembly — 2026-03-16Compare
  • 04/15/26 - Amended Assembly — 2026-04-15Compare
  • 05/22/26 - Amended Assembly — 2026-05-22Compare
  • 08/13/26 - Amended Senate — 2026-08-13Compare
  • 08/24/26 - Enrolled — 2026-08-24Compare
  • 08/31/26 - Chaptered — 2026-08-31Compare
  • (document, no version)Compare
  • AB2249Compare

Documents

Votes

  • Do pass as amended and be re-referred to the Committee on [Appropriations]

    2026-04-14 · pass · 17-0

    Member-level votes (19)
    • Elhawary: yes
    • Addis: yes
    • Pellerin: yes
    • Caloza: yes
    • Bains: yes
    • Irwin: yes
    • Jackson: yes
    • Bauer-Kahan: yes
    • Hart: yes
    • Hadwick: yes
    • Alanis: yes
    • Chen: yes
    • Haney: yes
    • Berman: yes
    • Ahrens: yes
    • Lowenthal: yes
    • Nguyen: yes
    • Macedo: other
    • Johnson: other
  • Do pass.

    2026-05-14 · pass · 14-0

    Member-level votes (15)
    • Dixon: yes
    • Krell: yes
    • Sharp-Collins: yes
    • Tangipa: yes
    • Wicks: yes
    • Pacheco: yes
    • Caloza: yes
    • Fong: yes
    • Calderon: yes
    • Hoover: yes
    • Pellerin: yes
    • Solache: yes
    • Aguiar-Curry: yes
    • Mark González: yes
    • Ta: other
  • AB 2249 Irwin Assembly Third Reading

    2026-05-26 · pass · 69-0

    Member-level votes (80)
    • Hadwick: yes
    • Ward: yes
    • Patel: yes
    • Hart: yes
    • Valencia: yes
    • Ellis: yes
    • Jeff Gonzalez: yes
    • Wicks: yes
    • Gabriel: yes
    • Stefani: yes
    • Wallis: yes
    • Ahrens: yes
    • Alanis: yes
    • Nguyen: yes
    • Lee: yes
    • Patterson: yes
    • Harabedian: yes
    • Connolly: yes
    • Flora: yes
    • Ramos: yes
    • Ortega: yes
    • Chen: yes
    • Papan: yes
    • Soria: yes
    • Arambula: yes
    • Zbur: yes
    • Solache: yes
    • Pacheco: yes
    • Ávila Farías: yes
    • Garcia: yes
    • Mark González: yes
    • Caloza: yes
    • Krell: yes
    • Alvarez: yes
    • Aguiar-Curry: yes
    • Blanca Rubio: yes
    • Berman: yes
    • Bauer-Kahan: yes
    • Schultz: yes
    • Bennett: yes
    • Gallagher: yes
    • Sharp-Collins: yes
    • Tangipa: yes
    • Bonta: yes
    • Davies: yes
    • McKinnor: yes
    • Gipson: yes
    • Ransom: yes
    • Petrie-Norris: yes
    • Quirk-Silva: yes
    • Calderon: yes
    • Lowenthal: yes
    • Bains: yes
    • Dixon: yes
    • Hoover: yes
    • Carrillo: yes
    • Boerner: yes
    • Elhawary: yes
    • Castillo: yes
    • Fong: yes
    • Irwin: yes
    • Schiavo: yes
    • Kalra: yes
    • Addis: yes
    • Bryan: yes
    • Rivas: yes
    • Jackson: yes
    • Pellerin: yes
    • Michelle Rodriguez: yes
    • Haney: other
    • Rogers: other
    • Lackey: other
    • Macedo: other
    • Wilson: other
    • DeMaio: other
    • Johnson: other
    • Celeste Rodriguez: other
    • Muratsuchi: other
    • Sanchez: other
    • Ta: other
  • Do pass, but first be re-referred to the Committee on [Appropriations]

    2026-06-08 · pass · 9-0

    Member-level votes (11)
    • Archuleta: yes
    • Menjivar: yes
    • Caballero: yes
    • Smallwood-Cuevas: yes
    • Strickland: yes
    • Niello: yes
    • Arreguín: yes
    • Grayson: yes
    • Wahab: yes
    • Umberg: other
    • Choi: other
  • Placed on suspense file

    2026-06-22 · pass · 6-0

    Member-level votes (7)
    • Cervantes: yes
    • Cabaldon: yes
    • Seyarto: yes
    • Dahle: yes
    • Wahab: yes
    • Richardson: yes
    • Grayson: other

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_api_sync, retrieved 2026-09-04T05:18:22.541076Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=AB 2249. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.